About SpyGlassPharma
SpyGlassPharma is a private company based in Aliso Viejo, California. It has reported $134,792,329 raised in four offerings on Form D since June 2019. Its chief executive is Patrick Mooney.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 30, 2025 | Jun 5, 2025 | $74,999,989fully sold | 10 | $7.4M | EquityRule 506(b) | Form D ↗ |
| Jul 6, 2023 | Jul 11, 2023 | $40,009,993of $90.0M target | 7 | $5.7M | EquityRule 506(b) | Form D ↗ |
| Dec 29, 2020 | Jan 5, 2021 | $13,749,996of $37.4M target | 4 | $3.4M | EquityRule 506(b) | Form D ↗ |
| May 22, 2019 | Jun 5, 2019 | $6,032,351fully sold | 2 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $134,792,329 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SpyGlassPharma's Form D filed Jun 5, 2025.
JM
Jake Merrill
Director
MK
Malik Kahook
Executive officer and director
GP
BK
Bilal Khan
Director
CY
Cynthia Yee
Director
RZ
Roger Zhang
Director
PM
Patrick Mooney
Chief Executive Officer and director
AB
ZS
Zach Scheiner
Director
Earlier filings also listed Tak Cheung (director, last listed Jan 2021), Kirk Nielsen (director, last listed Jan 2021) and Glenn Sussman (chief executive officer and director, last listed Jan 2021).